• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

p16 mutations in pancreatic cancer and its clinical application using pancreaitc juice

Research Project

Project/Area Number 09670524
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionKanazawa University

Principal Investigator

WATANABE Hiroyuki  Kanazawa Univ., Cancer Res.Inst., Res.Associate, がん研究所, 助手 (30242564)

Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1998: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1997: ¥1,400,000 (Direct Cost: ¥1,400,000)
Keywordsp16 mutations / pancreatic cancer / immunohistochemistry / pancreatic juice / microdissection / homozygous deletion / PCR-SSCP / p16mutations / p16 / 免疫組織染色 / K-ras
Research Abstract

I have repoted that detection of K-ras mutations in pure pancreatic juice (PPJ) was useful for the diagnosis of pancreatic carcinoma (PCa). However, combination assay of K-rag and p53 mutations was not completely fulfiled for the diagnosis of PCa. Therefore, a new specific gene for PCa is needed for the supplemental diagnosis of PCa. p16 is a suppressor gene with the function of cyclin dependent kinase (CDK) inhibitor, and high incidence of p16 inactivation in PCa cell lines was recently reported.
Expression of p1 6 gene product in human PCa was investigated in paraffin-embedded tissue using a monclonal antibody against p16 protein, clone G175-405, by means of immunohistochemical staining. All six cases of normal pancreas and all but 1 of 20 cases of chronic pancreatitis (CP) expressed p16 protein, whereas 41.9% (26 of 62) of PCas lost p16 expression. There was a significant difference between CP and PCa for frequency of the loss of p16 expression. (p< 0.01). Moreover loss of p16 protei … More n in pancreatic malignancy was significantly associated with histological grade (G1 versus G2 and G3, p< 0.01) but not with sex, age, clinical stage, tumor location, or resectability. DNA was extracted using microdissection method from the 26 PCa tissues which show the loss of p16 expression by immunohistochemical staining. Incidence of homozygous deletion was found in 19.2% (5/26) in exon 1, 23.1% (6/26) in exon 2, 0% (0/26) in exon 3 ofpl6, and 34.6% (9126) in all by PCR with the corresponding primers. On the other hand, there was no mutaion of p1 6 gene about the remnant 17 PCa cases expressing PCR products by PCR-SSCP.Recently, methylation of CpG island is regarded as a cause of the loss of p16 expression and p16 methylation for PCa is now under investigation. It is very difficult to detect homozygous deletions of p16 in PPJ because an amount of exfoliated normal pancreatic epitheliums are present in PPJ.Therefore, mutation of p16 in PPJ obtained from patients with PCa is under investigation. At present, there has been no detectable mutations of p16 in PPJ. Less

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Hu Y-X et al.: "Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma." Clin.Cancer Res.3. 1473-1477 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hu Y-X et al.: "Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma." Clin.Cancer Res.4. 1147-1152 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Watanabe H et al.: "Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay." Pancreas. 17. 341-347 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Taga H et al.: "Large duodenal tumor with positive K-ras mutation mimicking lateral spreading tumor of the colon." Dig.Endosc.11. 70-75 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hu Y-X et al.: "Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma." Br.J.Cancer. in press.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yamaguchi Y et al.: "Detection of mutations of p53 tumor suppressor gene in pancreatic juice juiceand its application to diagnosis of patients with pancreatic cancer-comparing with K-ras mutatio." Clin.Cancer Res.in press.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hu Y-X,Watanabe H,Ohtsubo K,Yamaguchi Y,Ha A,Okai T,and Sawabu N.: "Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma." Clin Cancer Res. 3. 1473-1477 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hu Y-X,Watanabe H,Ohtsubo K,Yamaguchi Y,Ha A,Motoo Y,Okai T,and Sawabu N.: "Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma." clin Cancer Res. 4. 1147-1152 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Watanabe H,Yamaguchi Y,HaA,Hu Y-X,Motoo Y,Okai T,and Sawabu N.: "Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay." Pancreas. 17. 341-347 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Taga H,Watanabe H,Yamaguchi Y,Ohtsubo K,Ha A,Hu Y-X,Motoo Y,Okai T,Mizoguchi M,Mai M,Kawashima A,and Sawabu N.: "Large duodenal tumor with positive K-ras mutation mimicking lateral spreading tumor of the colon." Dig Endosc. 11. 70-75 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hu Y-X,Watanabe H,Ohtsubo K,Yamaguchi Y,Ha A,Motoo Y,Okai T,and Sawabu N.: "Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma." Br J Cancer. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yamaguchi y, Watanabe H,Songur Y,Ohtsubo K,Motoo Y,Okai T,and Sawabu N.: "Detection of mutations of p53 tumor suppressor gene in pancreatic juice Juice and its application to diagnosis of patients with pancreatic cancer-comparing with K-ras mutation." Clin Cancer Res. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hu Y-X et al.: "Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma." Clin.Cancer Res.3・9. 1473-1477 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Hu Y-X et al.: "Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma." Clin.Cancer Res.4・5. 1147-1152 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Watanabe H et al.: "Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay." Pancreas. 17・4. 341-347 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Taga H et al.: "Large duodenal tumor with positive K-ras mutation mimicking lateral spreading tumor of the colon." Dig.Endosc.11・1. 70-75 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Hu Y-X et al.: "Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma." Br.J.Cancer. in press.

    • Related Report
      1998 Annual Research Report
  • [Publications] Yamaguchi Y et al.: "Detection of mutations of p53 tumor suppressor gene in pancreatic juice juice and its application to diagnosis of patients with pancreatic cancer-comparing with K-ras mutation." Clin.Cancer Res.in press.

    • Related Report
      1998 Annual Research Report
  • [Publications] Hu,Y.X.et al: "Frequent loss of p16 expression and its correlation with clinicopathologikal parameters in pancreatic carcinoms." Clin,Cancer Res.3. 1473-1477 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Watanabe,H.et al: "Quantitstive determination of K-ras mutations in pancrestic Juio for diagnosis of pancreatic cancer using hybidigation protection assoy." Pancreas. (in press). (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] 岡井高他: "小膵癌(結節型)診断のアルゴリズム-画像診断,膵液K-ras遺伝子" 胆と膵. 19. 55-60 (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] Motoo,Y.et al: "Sderosing pancreatitis showing rapidly progressive changes with recurent mass formation." Int.J.Pancreatol.21. 85-90 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 澤武紀雄 他: "肝胆膵癌関連腫瘍マーカー総論" 肝胆膵. 34. 687-695 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Hu,Y.X.et al: "Infrequent expression of p21 is related to altered p53 protein in panerestic carcimoma." Clin,Cancer Res.(in press). (1998)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi